NCT05515341

A DirEct to PatieNt Study in Chronic Pain

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50,000 (estimated)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Not accepted

Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Conditions

• Chronic Pain

Interventions

Type	Name	Description
DEVICE	Commercially Approved Interventional Medical Device/Therapy for Chronic Pain	Commercially Approved Interventional Medical Device/Therapy

Timeline

• Start date: 2023-01-10
• Primary completion: 2029-12-01
• Completion: 2029-12-01
• First posted: 2022-08-25
• Last updated: 2026-04-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study